➤ Prevention of infection for people with chemotherapy-induced neutropenia (CIN) includes recommendations that patients practice good hand hygiene with soap and water or alcoholbased hand rubs, that healthcare providers wear gowns when patients have respiratory secretions, and that visits from individuals with respiratory symptoms be avoided.
➤ A number of widely practiced interventions for the prevention of infection in patients with cancer and CIN, such as lowbacterial diets and inpatient isolation procedures, lack strong empirical evidence.
➤ The quality of life of patients who experience CIN and their families is negatively affected by this complication.
➤ Patient management and education for those at risk for developing CIN currently are not standardized.
I
n Part I of this two-part white paper, the project team of the State of the Knowledge on Neutropenia Symposium summarized the available evidence regarding chemotherapy-induced neutropenia (CIN), neutrophil physiology, chemotherapy dose intensity, approaches to risk assessment, national practice guidelines, and outcomes of neutropenia. The authors identifi ed what currently is known and, importantly, what is not known about the most common dose-limiting toxicity of cancer chemotherapy. CIN affects all aspects of patients' lives, the healthcare system, and society. Downstream effects have been identifi ed that are related to anti-infective use, either prophylactically or from treating actual infections resulting from the development of resistant organisms. This article presents the results of the team's literature review and discussion at the symposium pertaining to nursing interventions to prevent infection, patient education ONCOLOGY NURSING SOCIETY WHITE PAPER Purpose/Objectives: To summarize the current available evidence for oncology nurses so that they may predict and prevent complications of chemotherapy-induced neutropenia (CIN), provide optimal education to patients, and become familiar with the state of the knowledge of neutropenia by understanding the evidence and guidelines for patients with cancer who may experience CIN.
Data Sources: Review of primary literature, meta-analyses, available systematic reviews, clinical practice guidelines, and discussions at the State of the Knowledge on Neutropenia Symposium.
Data Synthesis: The evidence for nursing interventions to prevent CIN complications is underdeveloped. Strong empirical support to prevent infection in patients with CIN (e.g., restrictions in diet, isolation procedures, providing accurate patient education) is lacking. Several areas of preventive measures by patients, hand washing, and skin care have a stronger evidence base and should have high priority on patient education plans.
Conclusions: Strong evidence is available for several nursing interventions to prevent infection in patients with CIN. Many existing practices lack empirical support and should be identifi ed and reviewed in the clinical setting for appropriate patient management.
Implications for Nursing: Oncology nurses can use the fi ndings from the symposium to revise their care standards for patients anticipated to experience CIN. Research and practice performance improvement projects may be undertaken by oncology nurses to improve the delivery of evidence-based nursing care to this vulnerable patient population. This material is protected by U.S. copyright law. Unauthorized reproduction is prohibited. To purchase quantity reprints, please e-mail reprints@ons.org or to request permission to reproduce multiple copies, please e-mail pubpermissions@ons.org.
